Emergent BioSolutions EBS
NYSE EBS
$6.29 -0.07 (-1.10%)
As of: Oct 20, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Interest Expenses (2011 - 2026)

Updated

Emergent BioSolutions' Interest Expenses was $10 million in Q2 2026, down 32.0% from $14.7 million a year earlier and down 9.1% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Interest Expenses (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Emergent BioSolutions' Interest Expenses was $50.9 million through Jun 30, 2026, down 3.0% year-over-year; for FY2025, it came in at $59.3 million, down 16.5% from FY2024.

  • Interest Expenses shows a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
  • In earlier years, Interest Expenses was $71 million in FY2024 (-19.2%), $87.9 million in FY2023 (+135.7%), $37.3 million in FY2022 (+8.1%) and $34.5 million in FY2021 (+10.2%).
  • The Q2 2026 figure marks the lowest quarterly Interest Expenses since Q3 2024.
  • Compared with a year earlier, Interest Expenses has declined for three straight quarters, with an average decline of 17.7% over the last eight quarters.
  • The best year-over-year quarter for Interest Expenses over five years was Q2 2023 (growth of 266.7%); the worst was Q3 2024 (a decline of 57.9%).
  • Per Business Quant data, EBS's Interest Expenses in the three quarters before Q2 2026 was $11 million (Q1 2026), $14.7 million (Q4 2025) and $15.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 281.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 435.00 Mn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 247.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Emergent BioSolutions 325.34 Mn -425.56 Mn 137.20 Mn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.00 Mn
Mar 31, 2026 11.00 Mn
Dec 31, 2025 14.70 Mn
Sep 30, 2025 15.20 Mn
Jun 30, 2025 14.70 Mn
Mar 31, 2025 14.70 Mn
Dec 31, 2024 14.80 Mn
Sep 30, 2024 8.30 Mn
Jun 30, 2024 23.60 Mn
Mar 31, 2024 24.30 Mn
Dec 31, 2023 21.70 Mn
Sep 30, 2023 19.70 Mn
Jun 30, 2023 28.60 Mn
Mar 31, 2023 17.90 Mn
Dec 31, 2022 12.80 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 7.80 Mn
Mar 31, 2022 8.20 Mn
Dec 31, 2021 9.00 Mn
Sep 30, 2021 8.40 Mn
API Access

Emergent BioSolutions Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=EBS&period=max&api_key=YOUR_API_KEY